Benjamin Matthew Hause

USPTO Granted Patents = 7 (Patent Applications = 3)

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 23(Granted Patents)

Location History:

Currie, MN (2015)
Currie, MN (US) (2012 - 2023)

Company Filing History:

Years Active: 2012-2023

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11691817 - Yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol (2023-07-04),

2. 10899544 - Fermentation process using yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol (2021-01-26),

3. 9623105 - Attenuated swine influenza vaccines and methods of making and use thereof (2017-04-18),

4. 9446117 - Rotavirus subunit vaccines and methods of making and use thereof (2016-09-20),

5. 9278999 - Influenza C virus and vaccine (2016-03-08),

6. 9216211 - Attenuated swine influenza vaccines and methods of making and use thereof (2015-12-22),

7. 8137953 - Lactic acid-producing yeast cells having nonfunctional L- or D-lactate:ferricytochrome C oxidoreductase cells (2012-03-20),

Title: The Innovations of Benjamin Matthew Hause

Introduction

Benjamin Matthew Hause is an accomplished inventor based in Currie, Minnesota. He holds a total of seven patents, showcasing his significant contributions to the field of biotechnology. His work primarily focuses on genetically modified yeast cells, which have applications in fermentation processes.

Latest Patents

Hause's latest patents include innovations related to yeast cells that have disrupted the metabolic pathway from dihydroxyacetone phosphate to glycerol. These genetically modified yeast cells are designed to produce significantly less glycerol than wild-type strains while yielding greater amounts of desired fermentation products. Additionally, these yeast cells are capable of producing organic acids, such as lactate, and demonstrate robust growth even with reduced glycerol production.

Career Highlights

Throughout his career, Hause has worked with notable companies, including Cargill Inc. and Merial Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.

Collaborations

Hause has collaborated with esteemed colleagues, including Aristos Aristidou and Catherine Asleson Dundon. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

Benjamin Matthew Hause's innovative work in the realm of genetically modified yeast cells has the potential to revolutionize fermentation processes. His contributions are a testament to the importance of innovation in biotechnology.

This text is generated by artificial intelligence and may not be accurate.